“SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs”. 2014. Mediterranean Journal of Hematology and Infectious Diseases 6 (1): e2014003. https://doi.org/10.4084/mjhid.2014.003.